TIA and minor stroke: assessment and urgency

Also known as Transient ischaemic attack · Minor stroke · Mini stroke · ABCD2 score

GP-fellowship guide to TIA and minor stroke: the tissue-based definition that replaced time-based labels, ABCD2 scoring with its real performance and limitations, the urgent-treatment evidence (EXPRESS: 90-day stroke risk cut from 10.3% to 2.1%), dual antiplatelet therapy per CHANCE and POINT with bleeding trade-offs, carotid endarterectomy thresholds from NASCET/ECST pooled data, AF anticoagulation timing per ELAN, driving rules, and the mimics that fool everyone.

high13 referencesUpdated 22 Aug 20267 min readSource-verified · Sept 2026

Practise this topic

Key points

A TIA is now defined by tissue, not time: any transient focal neurological episode without infarction on imaging — most resolve within an hour, but duration no longer excludes the diagnosis.
Treat as an emergency: urgent specialist assessment within 24 hours plus immediate treatment cut 90-day recurrent stroke risk from 10.3% to 2.1% in EXPRESS.^[3]
Aspirin 300 mg immediately after haemorrhage exclusion, then dual antiplatelet therapy (clopidogrel 300–600 mg load then 75 mg + aspirin) for 21 days in minor stroke/high-risk TIA — CHANCE reduced stroke from 11.7% to 8.2%, POINT confirmed benefit but flagged bleeding (major haemorrhage HR 2.32).^[3]^[5]^[6]
Symptomatic carotid stenosis of 70% or more earns endarterectomy (absolute 5-year ipsilateral stroke reduction 16%) — ideally within two weeks of the event.^[7]^[9]

Overview

A transient ischaemic attack (TIA) was historically defined by symptoms resolving within 24 hours. That definition is dead: modern practice uses a tissue-based definition — a transient episode of focal neurological dysfunction caused by brain or retinal ischaemia without infarction on imaging. Symptoms lasting minutes can show infarction; symptoms lasting hours may not. The distinction matters because imaging-confirmed events carry higher recurrence risk than time-based labels alone suggest.^[13]

The stakes are front-loaded: recurrent stroke risk reaches up to 10% within the first week after TIA or minor stroke, which makes the week following presentation the highest-yield window for intervention in all of cerebrovascular medicine.^[3] EXPRESS proved what urgency buys: when assessment delay fell from 3 days to under 1 day and treatment initiation from 20 days to 1 day, 90-day recurrent stroke fell from 10.3% to 2.1%.^[3]

Risk does not end at 90 days: five-year follow-up of the international TIAregistry cohort shows 12.9% cumulative cardiovascular events, with strokes occurring at 9.5% over five years — and nearly half those strokes arriving in years two through five.^[4] Secondary prevention is therefore lifelong work.

References13Show

[1]Johnston SC, Rothwell PM, Nguyen-Huynh MN, et al. Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack Lancet, 2007.PMID 17258668
[2]Rothwell PM, Giles MF, Flossmann E, et al. A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack Lancet, 2005.PMID 15993230
[3]Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study) Lancet, 2007.PMID 17928046
[4]Amarenco P, Lavallée PC, Monteiro Tavares L, et al. Five-Year Risk of Stroke after TIA or Minor Ischemic Stroke N Engl J Med, 2018.PMID 29766771
[5]Wang Y, Wang Y, Zhao X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) N Engl J Med, 2013.PMID 23803136
[6]Johnston SC, Easton JD, Farrant M, et al. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA (POINT) N Engl J Med, 2018.PMID 29766750
[7]Barnett HJM, Taylor DW, Haynes RB, et al. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis N Engl J Med, 1991.PMID 1852179
[8]European Carotid Surgery Trialists Collaborative Group Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) Lancet, 1998.PMID 9593407
[9]Rothwell PM, Eliasziw M, Gutnikov SA, et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis Lancet, 2003.PMID 12531577
[10]Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association Stroke, 2021.PMID 34024117
[11]Rohner R, Kneihsl M, Goeldlin MB, et al. Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation (ELAN) Circulation, 2024.PMID 38753452
[12]Hoshino T, Uchiyama S, Wong LKS, et al. Differences in Characteristics and Outcomes Between Asian and Non-Asian Patients in the TIAregistry.org Stroke, 2017.PMID 28584002
[13]Giles MF, Albers GW, Amarenco P, et al. Early stroke risk and ABCD2 score performance in tissue- vs time-defined TIA: a multicenter study Neurology, 2011.PMID 21865578